Ciprofloxacin Lactate Injection (Cipulox)
Ciprofloxacin Lactate Injection (Cipulox)
Ciprofloxacin Lactate Injection (Cipulox),
FORMULATION: Each ml contains: Ciprofloxacin (as lactate), USP………… 2 mg
PRODUCT DESCRIPTION: Ciprofloxacin (Cipulox) is available as a clear, colorless solution for infusion.
PHARMACOKINETICS: Ciprofloxacin is a synthetic broad-spectrum antibacterial agent classified as a fluoroquinolone. Ciprofloxacin is an effective antibacterial agent for most of the Gram-negative and some of the Gram-positive aerobes but is generally less effective against anaerobic bacteria. Ciprofloxacin has a rapid bactericidal action brought about by the inhibition of DNA gyrase and topoisomerase IV during the proliferation phase of bacterial chromosomal division. For many Gram-negative bacteria, DNA gyrase is the primary target while in Gram-positive bacteria topoisomerase IV is the primary target of the quinolone class of antibacterial agent. Development of plasmid-mediated resistance as observed with ß-lactam antibiotics, aminoglycosides and tetracycline has not been observed with ciprofloxacin.
Pack Size: 1’s (100mL)
Exp: Apr 2025
Carton Size: 80 Vials
Ciprofloxacin Lactate Injection (Cipulox),
FORMULATION: Each ml contains: Ciprofloxacin (as lactate), USP………… 2 mg
PRODUCT DESCRIPTION: Ciprofloxacin (Cipulox) is available as a clear, colorless solution for infusion.
PHARMACOKINETICS: Ciprofloxacin is a synthetic broad-spectrum antibacterial agent classified as a fluoroquinolone. Ciprofloxacin is an effective antibacterial agent for most of the Gram-negative and some of the Gram-positive aerobes but is generally less effective against anaerobic bacteria. Ciprofloxacin has a rapid bactericidal action brought about by the inhibition of DNA gyrase and topoisomerase IV during the proliferation phase of bacterial chromosomal division. For many Gram-negative bacteria, DNA gyrase is the primary target while in Gram-positive bacteria topoisomerase IV is the primary target of the quinolone class of antibacterial agent. Development of plasmid-mediated resistance as observed with ß-lactam antibiotics, aminoglycosides and tetracycline has not been observed with ciprofloxacin.
Pack Size: 1’s (100mL)
Exp: Apr 2025
Carton Size: 80 Vials
New Arrival
Featured Products
Related products
-
Injectables
MECOBALAMIN (MINE) 500 mcg/mL
-
Injectables
OMEPRAZOLE (SIDPRAZOLE) 40 mg
-
Injectables
Piperacillin+Tazobactam (EVECITAM) 4 g/500 mg
-
Injectables
Ketorolac Trometamol (Oradol) 5 mg/mL
-
Injectables
B-VITAMINS B1+B6+B12 (NURAMINE FORTE) IM/IV